Dolby Laboratories, Inc.Class A (DLB)
NYSE Market Closed
Dolby Laboratories, Inc. develops audio, imaging and media technologies used to improve the way entertainment and communications are captured, distributed and experienced. The company is best known for formats and platforms such as Dolby Atmos and Dolby Vision, which are used in cinemas, televisions, smartphones, soundbars, computers, streaming services, music platforms and gaming devices.
Dolby’s core business model is built around intellectual property. It licenses its technologies, trademarks and patent portfolio to consumer electronics manufacturers, software providers, content distributors and other partners that integrate Dolby capabilities into their products or services. This licensing-driven approach allows the company to participate in large entertainment and device markets without relying primarily on manufacturing volume.
The company also sells cinema-related products and services. These include hardware and software used for digital cinema playback, media processing, encryption, packaging and premium theatrical experiences. Dolby technologies are used by filmmakers, studios, broadcasters and streaming platforms to create more immersive sound and more dynamic visual presentation, helping content retain quality across theaters, home entertainment systems and mobile devices.
Dolby operates globally, with revenue generated in the United States and international markets. Its position is distinctive because it sits at the intersection of entertainment creation, content distribution and consumer hardware. The value of its brand depends on broad industry adoption, continued innovation in audio and video standards, and the willingness of device makers and media companies to market premium experiences under Dolby names. For investors, Dolby represents a technology licensing company tied closely to the evolution of digital media, connected devices and premium entertainment formats.
Last updated
- Market Cap
- 5.06B
- P/E
- 20.75
- P/FCF
- 16.77
- P/S
- 3.7
- Enterprise Value
- 4.46B
- Sector
- Financials
- Industry
- Patent Owners and Lessors
- Address
- 1275 MARKET STREET, SAN FRANCISCO, CA, 94103
No recent news is linked to this listing.
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 5.06B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 4.46B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 20.75
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.93
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 3.7
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 12.3
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 3.27
- EPS
- 2.58
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 2.65%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 16.77
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 14.96
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 301.47M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 9.31%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 7.5%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.81
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 2.75
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 1.25
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 849.45K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 53.44
Income Statement
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Revenue | 395.63M | 346.71M | 307.02M | 315.55M | 369.56M |
| Gross profit | 350.9M | 303.5M | 267.51M | 271.54M | 333.72M |
| Operating income | 112.95M | 62.16M | 29.68M | 47.64M | 107.76M |
| EBITDA | 139.23M | 96.77M | 57.8M | 69.02M | 133.51M |
| Net income | 94.92M | 53.33M | 49.33M | 46.07M | 91.79M |
| Basic EPS | 1 | 0.56 | 0.52 | 0.48 | 0.95 |
| Diluted EPS | 0.99 | 0.55 | 0.51 | 0.48 | 0.94 |
Balance Sheet
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Total assets | 3.25B | 3.19B | 3.23B | 3.2B | 3.23B |
| Total liabilities | 622.36M | 589.25M | 595.81M | 581.75M | 646.02M |
| Total equity | 2.63B | 2.6B | 2.63B | 2.61B | 2.58B |
| Cash & equivalents | 594.28M | 643.85M | 701.89M | 698.57M | 626.55M |
| Current assets | 1.34B | 1.32B | 1.3B | 1.28B | 1.27B |
| Current liabilities | 474.61M | 443.51M | 437.79M | 388.79M | 457.49M |
Cash Flow
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Operating cash flow | 92.51M | 54.8M | 122.83M | 67.69M | 174.9M |
| Investing cash flow | -46.09M | 1.25M | -21.91M | -6.43M | 25.9M |
| Financing cash flow | -99.88M | -121.83M | -64.06M | -60.74M | -64.87M |
| Change in cash | -53.76M | -65.8M | 36.8M | 6.22M | 138.69M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SCHEDULE 13G/A — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 4 — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 144 — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Couling John D | View Filing | |
| form 4 | Form 4 — Couling John D | View Filing | |
| form 4 | Form 4 — Couling John D | View Filing | |
| form 4 | Form 4 — Couling John D | View Filing | |
| edgar index | SD — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 4 — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 144 — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Pendleton Todd | View Filing | |
| edgar index | 4 — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Revankar Shriram | View Filing | |
| edgar index | 144 — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Revankar Shriram | View Filing | |
| edgar index | 4 — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 144 — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Park Robert J | View Filing | |
| form 4 | Form 4 — Park Robert J | View Filing | |
| edgar index | SCHEDULE 13G/A — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 4 — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 144 — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Couling John D | View Filing | |
| form 4 | Form 4 — Couling John D | View Filing | |
| form 4 | Form 4 — Couling John D | View Filing | |
| form 4 | Form 4 — Couling John D | View Filing | |
| edgar index | 144 — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Couling John D | View Filing | |
| edgar index | SCHEDULE 13G — Dolby Laboratories, Inc. | View Filing | |
| edgar index | SCHEDULE 13G — Dolby Laboratories, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 4 — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 144 — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Rollins Emily | View Filing | |
| edgar index | SCHEDULE 13G/A — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 4 — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| edgar index | 4 — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 4 — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 144 — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Revankar Shriram | View Filing | |
| edgar index | 4 — Dolby Laboratories, Inc. | View Filing | |
| edgar index | SCHEDULE 13D/A — Dolby Laboratories, Inc. | View Filing | |
| edgar index | 144 — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Nicholson Ryan | View Filing | |
| form 4 | Form 4 — Nicholson Ryan | View Filing | |
| form 4 | Form 4 — Nicholson Ryan | View Filing | |
| edgar index | SCHEDULE 13G/A — Dolby Laboratories, Inc. | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — Dolby Dagmar | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing | |
| form 4 | Form 4 — DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free